Back to discover
Disease

Lipedema

Clinical development underwayEmerging research
MeSHLipedema
1
Publications
1
Clinical trials
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
0
Active
0
Late-stage
1
Completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes1
  • Lipedema1
Leading journals1
  • International journal of molecular sciences1
Leading researchers7
  • Bortolon M1
  • Cannataro R1
  • Cione E1
  • Gabriele G1
  • Patton L1
  • Ricolfi L1
  • Zolesio P1
Affiliations (unnormalised)6
  • Endocrinology and Lymphology Clinic1
  • Galascreen Laboratories1
  • Lymphology Clinic1
  • Rehabilitation Unit and Lymphology Clinic1
  • University of Calabria1
  • University of Siena1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Disorder of adipose tissue characterized by symmetric and bilateral enlargement of the lower extremities due to abnormal deposition of SUBCUTANEOUS FAT often in obese women. It is associated with HEMATOMA, pain and may progress to secondary LYMPHEDEMA which is known as lipolymphedema.

Identifiers
MeSHLipedema
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.